Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8883818
Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
granted -
US 8883781
Thienopyrimidines useful as modulators of ion channels
granted -
US 8883766
Ion channel modulators and methods of use
granted -
US 8883729
Nanolipoprotein particles and related compositions, methods and systems
granted -
US 8883448
Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes
granted -
US 8883500
Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy
granted -
US 8883214
Implantable delivery vehicle for ocular delivery of muscarinic antagonists
granted -
US 8883438
Method for diagnosing cell proliferation disorders having a neoactive mutation at residue 97 of isocitrate dehydrogenase 1
granted -
US 8883211
Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds
granted -
US 8883202
Lipid compositions
granted -
US 8883189
Intraocular encapsulation of oxygenic bacteria
granted -
US 8883185
Hydrogel implants with varying degrees of crosslinking
granted -
US 8883155
Methods for treating hematopoietic malignancies
granted -
US 8883154
Antibody-mediated modulation of allergy
granted -
US 8883174
Compositions for stimulation of mammalian innate immune resistance to pathogens
granted -
US 8883161
Fusion polypeptide against EB virus-induced tumor and colicin Ia mutant
granted -
US 8875970
Structure containing wound treatment material
granted -
US 8877917
Glycoconjugates of RNA interference agents
granted -
US 8877796
Spiro-oxindole MDM2 antagonists
granted -
US 8877765
Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer
granted -
US 8877797
Methods for treating Parkinson's disease using pro-neurogenic compounds
granted -
US 8877914
Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes
granted -
US 8877726
Method and medicament for inhibiting the expression of a given gene
granted -
US 8877721
Small activating RNA molecules and methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.